Paper39625652
YTHDF2-dependent m6A modification of FOXO3 mRNA mediates TIMP1 expression and contributes to intervertebral disc degeneration following ROS stimulation.
Wang F and 4 others. Cell Mol Life Sci, 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. YTHDF2-dependent m6A modification of FOXO3 mRNA mediates TIMP1 expression and contributes to intervertebral disc degeneration following ROS stimulation. Papers, record 39625652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39625652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- YTHDF2-dependent m6A modification of FOXO3 mRNA mediates TIMP1 expression and contributes to intervertebral disc degeneration following ROS stimulation.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intervertebral Disc Degeneration | Major topic |
| Forkhead Box Protein O3 | Major topic |
| Tissue Inhibitor of Metalloproteinase-1 | Major topic |
| Hydrogen Peroxide | Major topic |
| Reactive Oxygen Species | Major topic |
| RNA, Messenger | Major topic |
| RNA-Binding Proteins | Major topic |
| Mice, Inbred C57BL | Major topic |
| Animals | |
| Mice | |
| Nucleus Pulposus | |
| Adenosine | |
| Male | |
| Intervertebral Disc |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32211588 | Pathomechanism of intervertebral disc degeneration. | JOR Spine | 2020 | https://conductscience.org/library/papers/32211588 | PubMed |
| 2 | 35978054 | The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights. | Exp Mol Med | 2022 | https://conductscience.org/library/papers/35978054 | PubMed |
| 3 | 33391459 | Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions. | Theranostics | 2021 | https://conductscience.org/library/papers/33391459 | PubMed |
| 4 | 38167807 | Serglycin secreted by late-stage nucleus pulposus cells is a biomarker of intervertebral disc degeneration. | Nat Commun | 2024 | https://conductscience.org/library/papers/38167807 | PubMed |
| 5 | 34354983 | Intervertebral Disk Degeneration: The Microenvironment and Tissue Engineering Strategies. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/34354983 | PubMed |
| 6 | 35846355 | Immuno-Modulatory Effects of Intervertebral Disc Cells. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35846355 | PubMed |
| 7 | 23369495 | Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. | Spine J | 2013 | https://conductscience.org/library/papers/23369495 | PubMed |
| 8 | 24166242 | Role of cytokines in intervertebral disc degeneration: pain and disc content. | Nat Rev Rheumatol | 2014 | https://conductscience.org/library/papers/24166242 | PubMed |
| 9 | 26162271 | MMPs and ADAMTSs in intervertebral disc degeneration. | Clin Chim Acta | 2015 | https://conductscience.org/library/papers/26162271 | PubMed |
| 10 | 36561567 | The role of oxidative stress in intervertebral disc cellular senescence. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36561567 | PubMed |
| 11 | 31813106 | ROS and diseases: role in metabolism and energy supply. | Mol Cell Biochem | 2020 | https://conductscience.org/library/papers/31813106 | PubMed |
| 12 | 33611339 | The role of m6A modification in the biological functions and diseases. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33611339 | PubMed |
| 13 | 31520073 | Reading, writing and erasing mRNA methylation. | Nat Rev Mol Cell Biol | 2019 | https://conductscience.org/library/papers/31520073 | PubMed |
| 14 | 33188361 | The epitranscriptome beyond m6A. | Nat Rev Genet | 2021 | https://conductscience.org/library/papers/33188361 | PubMed |
| 15 | 35340126 | m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35340126 | PubMed |
| 16 | 38600232 | Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification. | Sci Rep | 2024 | https://conductscience.org/library/papers/38600232 | PubMed |
| 17 | 36069931 | ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer. | Cancer Res | 2022 | https://conductscience.org/library/papers/36069931 | PubMed |
| 18 | 37576872 | Rapidly in situ forming an injectable Chitosan/PEG hydrogel for intervertebral disc repair. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/37576872 | PubMed |
| 19 | 27482708 | In Vivo Mouse Intervertebral Disc Degeneration Model Based on a New Histological Classification. | PLoS One | 2016 | https://conductscience.org/library/papers/27482708 | PubMed |
| 20 | 36403758 | Glucose-stimulated PGC-1α couples with CBP and Runx2 to mediate intervertebral disc degeneration through transactivation of ADAMTS4/5 in diet-induced obesity mice. | Bone | 2023 | https://conductscience.org/library/papers/36403758 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42733772 | Biomaterials for intervertebral disc regeneration: Niche reprogramming, precision therapeutics, and structural reconstruction. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42733772 | PubMed |
| 42625816 | Bibliometric analysis of research on spinal cord injury and the gut microbiota. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42625816 | PubMed |
| 42515673 | m1A and m6A RNA Methylations as Druggable Targets in Cancer. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515673 | PubMed |
| 42292221 | Clinical and imaging impact of diabetes mellitus on elderly patients with lumbar spinal stenosis: a retrospective propensity score-matched study with ≥5-year follow-up. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42292221 | PubMed |
| 42138387 | The m6A reader protein YTHDF2 facilitates HTLV-1 infectious and mitotic propagation by stabilizing Tax RNA. | J Virol | 2026 | https://conductscience.org/library/papers/42138387 | PubMed |
| 41884831 | Exploring the mechanisms underlying quercetin, a key component of Achyranthis Bidentatae Radix, against intervertebral disc degeneration. | Front Immunol | 2026 | https://conductscience.org/library/papers/41884831 | PubMed |
| 41660044 | Identifying druggable gene-related biomarkers in intervertebral disc degeneration through transcriptome sequencing and mendelian randomization analysis. | Front Genet | 2026 | https://conductscience.org/library/papers/41660044 | PubMed |
| 41575606 | Research progress on the mechanism of FOXO protein in sepsis. | Apoptosis | 2026 | https://conductscience.org/library/papers/41575606 | PubMed |
| 41244802 | Identification and validation of novel risk genes for intervertebral disc disorder by integrating large-scale multi-omics analyses and experimental studies. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41244802 | PubMed |
| 40986143 | The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | https://conductscience.org/library/papers/40986143 | PubMed |
| 40585531 | Development of a mechanical adaptable, moisture retention capable, injectable and adhesive organohydrogel for nucleus pulposus repairing. | Regen Biomater | 2025 | https://conductscience.org/library/papers/40585531 | PubMed |
| 40314795 | Role of oxidative stress in intervertebral disc degeneration: mechanisms, pathogenesis, and therapeutic strategies. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40314795 | PubMed |
| 40293529 | m6A-modified MIR670HG suppresses tumor liver metastasis through enhancing Kupffer cell phagocytosis. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40293529 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39625652
GET https://conductscience.org/api/papers/v1/39625652/references?page=2